Get the Stockscreener App
55.90
5.75%
3.04
Livanova Plc stock is traded at $55.90, with a volume of 728.02K.
It is up +5.75% in the last 24 hours and up +28.33% over the past month.
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
See More
Previous Close:
$52.86
Open:
$53.46
24h Volume:
728.02K
Relative Volume:
1.12
Market Cap:
$3.05B
Revenue:
$1.28B
Net Income/Loss:
$-222.15M
P/E Ratio:
-13.67
EPS:
-4.09
Net Cash Flow:
$145.52M
1W Performance:
+4.06%
1M Performance:
+28.33%
6M Performance:
+17.83%
1Y Performance:
+21.42%
1-Day Range:
$53.40
$55.99
1-Week Range:
$52.72
$55.99
52-Week Range:
$32.48
$57.35
Livanova Plc Stock (LIVN) Company Profile
Name
Livanova Plc
Sector
Industry
Phone
4402033250662
Address
20 EASTBOURNE TERRACE, LONDON
Compare LIVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
55.90 | 2.91B | 1.28B | -222.15M | 145.52M | -4.09 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-20-25 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Feb-26-25 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Oct-04-24 | Initiated | Goldman | Buy |
| Sep-17-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-20-24 | Reiterated | Needham | Buy |
| Feb-20-24 | Upgrade | Mizuho | Neutral → Buy |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Apr-14-23 | Initiated | Mizuho | Neutral |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Apr-06-22 | Initiated | Wolfe Research | Outperform |
| Feb-24-22 | Upgrade | UBS | Neutral → Buy |
| Dec-03-21 | Initiated | Goldman | Buy |
| Aug-20-21 | Reiterated | Needham | Buy |
| Jul-20-21 | Upgrade | Needham | Hold → Buy |
| Mar-03-21 | Downgrade | Berenberg | Buy → Hold |
| Jan-05-21 | Downgrade | Needham | Buy → Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Jun-26-20 | Reiterated | Needham | Buy |
| Oct-30-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Nov-28-18 | Initiated | UBS | Neutral |
| Aug-02-18 | Reiterated | Needham | Buy |
| Jun-08-18 | Initiated | Stifel | Buy |
| May-31-18 | Reiterated | Needham | Buy |
| Feb-28-18 | Reiterated | Needham | Buy |
View All
Livanova Plc Stock (LIVN) Latest News
Earnings call transcript: LivaNova Q2 2025 sees earnings beat, stock surges - Investing.com
LivaNova PLC Reaches Critical Trendline Support2025 Pullback Review & Verified Chart Pattern Signals - newsyoung.net
LivaNova PLC Recovery Hinges on Volume BreakoutGDP Growth & Stepwise Trade Signal Guides - mustnews.co.kr
LivaNova PLC Inches Above Key Support — Safe to HoldEarnings Growth Report & Precise Swing Trade Alerts - mustnews.co.kr
Improved Revenues Required Before LivaNova PLC (NASDAQ:LIVN) Stock's 27% Jump Looks Justified - 富途牛牛
LivaNova’s Essenz perfusion system launches in China - Investing.com
LivaNova's Expansion in China with the Essenz Perfusion System: A Strategic Catalyst for Growth in a High-Potential Market - AInvest
LivaNova Launches Essenz Perfusion System in China - Eagle-Tribune
Should value investors consider LivaNova PLCJuly 2025 News Drivers & Low Risk Profit Maximizing Plans - thegnnews.com
Optimistic Investors Push LivaNova PLC (NASDAQ:LIVN) Shares Up 28% But Growth Is Lacking - simplywall.st
Bollinger Band Squeeze Points to Volatility in LivaNova PLCJuly 2025 News Drivers & Low Volatility Stock Suggestions - beatles.ru
What earnings revisions data tells us about LivaNova PLCMarket Volume Summary & AI Driven Stock Movement Reports - Newser
LivaNova PLC Enters Reversal Setup in Weekly ChartsJuly 2025 Technicals & Capital Protection Trade Alerts - beatles.ru
Sentiment analysis tools applied to LivaNova PLCPortfolio Value Summary & Fast Exit and Entry Strategy Plans - Newser
Why LivaNova (LIVN) Is Up 12.0% After Strong Q2 Results and Raised 2025 Revenue Guidance - simplywall.st
LivaNova PLC stock trend forecast2025 Price Targets & Long-Term Capital Growth Strategies - Newser
Machine Learning Models Forecast LivaNova PLC UptickWeekly Trend Report & Low Risk Entry Point Guides - sundaytimes.kr
Visual trend scoring systems applied to LivaNova PLC [Quarterly Trade Review]Free Risk Managed Investment Strategies - Newser
Chart based exit strategy for LivaNova PLCFree Capital Preserving Trade Plan Templates - Newser
Single-Chamber Pacemaker Market to Reach $2.77 Billion by 2031, - openPR.com
What recovery options are there for LivaNova PLCRisk/Reward Optimization Entry Point Analysis - Newser
LivaNova (LIVN) Is Up 18.7% After Strong Q2 Results and Raised 2025 Guidance – What's Changed - simplywall.st
Jefferies Reaffirms ‘Buy’ Rating on LivaNova PLC (LIVN) with $79 PT - MSN
How hedge fund analytics apply to LivaNova PLC stockAI Intraday Market Movement Prediction Tool - Newser
LivaNova PLC (NASDAQ:LIVN) Receives Average Recommendation of “Buy” from Analysts - Defense World
Can machine learning forecast LivaNova PLC recoveryFree Trade Ready Stock Watch for Short Term - Newser
LivaNova (NASDAQ:LIVN) Upgraded by Wall Street Zen to “Strong-Buy” Rating - Defense World
LivaNova PLC Company Revenue and Profit Trends: A Deep DiveSmart Risk Strategy with Entry Optimization - Newser
Real time scanner hits for LivaNova PLC explainedInvestment Position Summary with Timeframe Forecast - Newser
LivaNova PLC Reports Strong Q2 Earnings and Raised Guidance - The Globe and Mail
LivaNova (LIVN) Is Up 18.0% After Raising 2025 Outlook and Advancing Core Technology Platforms - simplywall.st
LivaNova PLC (NASDAQ:LIVN) Q2 2025 Earnings Call Transcript - Insider Monkey
Goldman Sachs raises Livanova stock price target to $168 on strong 2Q25 - Investing.com Nigeria
LivaNova Reports Strong Q2 2025 Revenue Growth, Raises Full-Year Guidance - AInvest
LivaNova raises 2025 organic growth outlook to 9%-10% with upgraded guidance for cardiopulmonary and epilepsy - MSN
Livanova stock price target raised to $65 from $55 at Mizuho - Investing.com Canada
LIVN Stock Price and Chart — NASDAQ:LIVN - TradingView
LivaNova Q2 2025 revenue increased 10.7% to USD 352.5M - Medical Buyer
Decoding LivaNova PLC (LIVN): A Strategic SWOT Insight - GuruFocus
LivaNova: Q2 Earnings Snapshot - Connecticut Post
LivaNova PLC Reports Strong Q2 2025 Results - TipRanks
LivaNova PLC (LIVN): Accelerating Growth in Neuromodulation and Cardiopulmonary Markets - AInvest
LivaNova Earnings: Strength in Cardiopulmonary Fuels Strong Second Quarter - Morningstar
LivaNova Has Found New Opportunities for Innovation in Its Strongholds - Morningstar
LivaNova Q2 2025 Earnings Call Transcript - MarketBeat
Transcript : LivaNova PLC, Q2 2025 Earnings Call, Aug 06, 2025 - MarketScreener
LivaNova stock rises before hours on Q2 beats, raised guidance - MassDevice
LivaNova PLC reports results for the quarter ended June 30Earnings Summary - TradingView
LivaNova Exceeds Q2 Earnings Expectations with Robust GrowthNews and Statistics - IndexBox
LivaNova (LIVN) Q2 Earnings and Revenues Beat Estimates - Yahoo Finance
LivaNova's Outperformance and Strategic Momentum in 2025: Why Revenue, Margin Expansion, and Clinical Innovation Justify a Buy Now Position in Medical Tech - AInvest
Livanova Plc Stock (LIVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Livanova Plc Stock (LIVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Bianchi Francesco | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
10,938 |
| SCHERMERHORN TODD C | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
9,473 |
| KOZY WILLIAM A | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
4,840 |
0 |
33,148 |
| Barry James Christopher | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
4,772 |
| Story Brooke | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
6,892 |
| Enxing Seng Stacy | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
12,161 |
| WILVER PETER M | Director |
Jun 15 '25 |
Option Exercise |
0.00 |
3,416 |
0 |
7,148 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '25 |
Option Exercise |
0.00 |
2,967 |
0 |
2,967 |
| Bolton Stephanie | President, Global Epilepsy |
Mar 30 '25 |
Option Exercise |
0.00 |
6,024 |
0 |
15,586 |
| Makatsaria Vladimir | Chief Executive Officer |
Mar 30 '25 |
Option Exercise |
0.00 |
9,330 |
0 |
9,330 |
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):